# Concept: Operating income(loss)

## Bilingual Labels
- **EN**: Operating income(loss)
- **KO**: 영업이익(손실)

- **ID**: dart:OperatingIncomeLoss

## Reported Numerical Facts

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member]**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 15,437,339,044 (decimals: 0)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 149,420,804,340 (decimals: 0)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 81,958,013,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: -41,581,083,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 5,283,243,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 2,491,448,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: All other segments [member]**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: ifrs-full:AllOtherSegmentsMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 425,760,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 1,081,667,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: Elimination of intersegment amounts [member]**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: ifrs-full:EliminationOfIntersegmentAmountsMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: -72,229,677,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 187,428,772,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Separate [member]**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:SeparateMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 28,784,806,251 (decimals: 0)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 136,422,755,477 (decimals: 0)

---
*Source Document: entity00413046_2025-03-31.xbrl*
## Embeddable Text (for FAISS)
```text
Concept: Operating income(loss)
Bilingual Labels
 EN: Operating income(loss)
 KO: 영업이익(손실)
 ID: dart:OperatingIncomeLoss
Reported Numerical Facts
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member]
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember >
 Period: 20240101 to 20240331
   Value: 15,437,339,044 (decimals: 0)
 Period: 20250101 to 20250331
   Value: 149,420,804,340 (decimals: 0)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember >
 Period: 20240101 to 20240331
   Value: 81,958,013,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 41,581,083,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember >
 Period: 20240101 to 20240331
   Value: 5,283,243,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 2,491,448,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: All other segments [member]
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: ifrsfull:AllOtherSegmentsMember >
 Period: 20240101 to 20240331
   Value: 425,760,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 1,081,667,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: Elimination of intersegment amounts [member]
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: ifrsfull:EliminationOfIntersegmentAmountsMember >
 Period: 20240101 to 20240331
   Value: 72,229,677,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 187,428,772,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Separate [member]
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:SeparateMember >
 Period: 20240101 to 20240331
   Value: 28,784,806,251 (decimals: 0)
 Period: 20250101 to 20250331
   Value: 136,422,755,477 (decimals: 0)
Source Document: entity00413046_20250331.xbrl
```